Vastarel MR 35 mg

Indication

Add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled by or intolerant to first-line antianginal therapies.

Ingredients

• Trimetazidine dihydrochloride 35 mg

Direction

Take orally as directed by a physician, usually one modified-release tablet twice daily with meals. Swallow whole. Read the enclosed leaflet carefully.

Side effects

• Dizziness and headache
• Gastrointestinal disturbances such as nausea and vomiting
• Movement disorders (parkinsonian symptoms
• tremor)
• Consult a doctor or pharmacist before use and stop if irritation or allergy occurs.

Precautions

• Prescription only medicine
• Not for treatment of an acute angina attack
• Keep out of the reach of children
• Consult a doctor or pharmacist before use and stop if irritation or allergy occurs.